T1	Participants 49 63	schizophrenia:
T2	Participants 226 242	in schizophrenia
T3	Participants 739 840	in schizophrenia patients with negative symptoms who were receiving second generation antipsychotics.
T4	Participants 841 861	Forty-three subjects
